In the BioHarmony Drug Report Database

"Preview" Icon

Triprolidine

Actidil (triprolidine) is a small molecule pharmaceutical. Triprolidine was first approved as Actidil on 1983-07-01. It is used to treat allergic conjunctivitis, atopic dermatitis, and rhinitis in the USA. The pharmaceutical is active against histamine H1 receptor.

 

Trade Name

 

Actidil
 

Common Name

 

triprolidine
 

ChEMBL ID

 

CHEMBL855
 

Indication

 

allergic conjunctivitis, atopic dermatitis, rhinitis
 

Drug Class

 

Image (chem structure or protein)

Triprolidine structure rendering